Skip to main content

Equity
Equity
43 members
0 questions
7 posts

The aim of this session is to describe the key questions for researchers to consider to promote health equity when developing or using outcome measures in rheumatology. We will present the results of a rapid review to assess equity considerations in patient-reported outcome measures.
In small groups, and considering the PROGRESS-Plus framework, discuss the following 2 questions:
1. In the development of a new instrument (for example to measure disease activity in rheumatoid arthritis) what are the key features that are likely to facilitate validation in a wide range of populations/groups to promote equity?
2. When selecting an existing instrument for a study, what are the important factors to consider to ensure wide participation in the study across under-represented populations?

Jennifer updated 4 months ago
Post
Here are the slides that were presented last week.
Jennifer commented 4 months ago
Post
Why adding 7 lines to the SOMP and not 1 column?
Jennifer commented 4 months ago
Post
There are many more facets to equity in instruments. For instance, equity in science. You have to think that most instruments we use are developed in the same countries, and English is the original language of most of them. The... (More)
Jennifer commented 4 months ago
Post
Great SIG thank you all. So for me, the key next steps are overarching objectives namely: - Should equity considerations for outcome measures be recommendations or guidelines (I think we decided not mandatory, yet) AND as a separate issue, should... (More)